Antiphosphlipid Syndrome Presented with Renovascular Hypertension
<p>Renovascular pathologies are one of the treatable causes of hypertension. Antiphospholipid syndrome develops owing to a heterogeneous group of antiphospholipid antibodies which causes various thrombotic problems. This entity may effects very small vessels and sometimes leads to hypertension...
Sábháilte in:
Príomhchruthaitheoirí: | Savas Ozturk (Údar), Mukremin Uysal (Údar), Fulya Cosan (Údar), Banu Buyukaydin (Údar), Murat Inanc (Údar), Reyhan Diz-Kucukkaya (Údar), Isın Kılıcarslan (Údar), Aydin Turkmen (Údar), Rumeyza Kazancioglu (Údar) |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
Archives of Clinical Nephrology - Peertechz Publications,
2016-06-16.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Pathophysiology and management of renovascular hypertension
de réir: Łukasz Dobrek
Foilsithe / Cruthaithe: (2020) -
Hematological indices in renovascular hypertension: A propensity score matching analysis
de réir: Ahmet Seyfeddin Gurbuz, et al.
Foilsithe / Cruthaithe: (2019) -
Hypertension crisis as the first symptom of renovascular hypertension in children
de réir: Lingling Xu, et al.
Foilsithe / Cruthaithe: (2022) -
Long-Term Outcomes of Pediatric Renovascular Hypertension
de réir: Hyun Chung, et al.
Foilsithe / Cruthaithe: (2017) -
Oxidative stress, the capo of endothelial dysfunction in chronic renovascular hypertension
de réir: Jung Tak Park, et al.
Foilsithe / Cruthaithe: (2014)